Clinical studies and case reports are showing much support for the use of stem cell therapy to treat autoimmune diseases. In mice subjects, one study showed efficacy of stem cells on experimental autoimmune hearing loss. Mice treated once a week for 6 weeks had improved anti-inflammatory cytokine induction and reduced inflammation. Some mice were found to have moderate improvements after treatment.
Regarding multiple sclerosis, researchers have proven that the progression of disease can be slowed or stopped, and some patients have shown improvement in motor function and quality of life. In 10 patients with polymyositis, stem cells were transplanted. Researchers found improvements with functional abilities after several treatments. Perhaps the best efficacy was noted in patients with rheumatoid arthritis. Researchers documented ability to stand without help or medications following stem cell therapy options. The study participants were previously unable to ambulate and chair-bound.
A large controlled study involved MS patients treated with stem cells. The patients received three injections of stem cells into the spinal fluid at 3-month intervals. Reports found a 70% improvement rate of 10 patients so far, and many reported reductions in level of disability. Overall, the ongoing study is showing promise for the use of stem cells to treat, alleviate symptoms of, and possibly cure MS.